Información del producto
SLX-2119 is a small molecule that has been shown to have anti-fibrotic properties. It inhibits the growth of 3T3-L1 preadipocytes and reduces the expression of growth factor-β1, which is a key mediator in fibrosis. This drug also has potential as a biomarker for kidney fibrosis and malignant brain tumors. SLX-2119 is able to inhibit ROCK2, which may be an important pathogenic mechanism in bowel disease. The drug is metabolized by CYP450 enzymes and its metabolites are excreted through urine or bile. This compound has been shown to cause cell lysis in vitro, but this effect has not been observed in vivo.
Propiedades químicas
Consulta técnica sobre: 3D-LLB41787 SLX-2119
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
